Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12173
Title: Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.
Austin Authors: Park, Saem Mul;Angel, Catherine E;McIntosh, Julie D;Mansell, Claudia J;Chen, Chun-Jen J;Cebon, Jonathan S ;Dunbar, P Rod
Affiliation: Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Melbourne, Victoria, Australia
School of Biological Sciences, The University of Auckland, Auckland, New Zealand.
School of Biological Sciences, The University of Auckland, Auckland, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, New Zealand.
Issue Date: 14-Apr-2014
Publication information: PLoS One 2014; 9(4): e94781
Abstract: The lymphatic sinuses in human lymph nodes (LNs) are crucial to LN function yet their structure remains poorly defined. Much of our current knowledge of lymphatic sinuses derives from rodent models, however human LNs differ substantially in their sinus structure, most notably due to the presence of trabeculae and trabecular lymphatic sinuses that rodent LNs lack. Lymphatic sinuses are bounded and traversed by lymphatic endothelial cells (LECs). A better understanding of LECs in human LNs is likely to improve our understanding of the regulation of cell trafficking within LNs, now an important therapeutic target, as well as disease processes that involve lymphatic sinuses. We therefore sought to map all the LECs within human LNs using multicolor immunofluorescence microscopy to visualize the distribution of a range of putative markers. PROX1 was the only marker that uniquely identified the LECs lining and traversing all the sinuses in human LNs. In contrast, LYVE1 and STAB2 were only expressed by LECs in the paracortical and medullary sinuses in the vast majority of LNs studied, whilst the subcapsular and trabecular sinuses lacked these molecules. These data highlight the existence of at least two distinctive populations of LECs within human LNs. Of the other LEC markers, we confirmed VEGFR3 was not specific for LECs, and CD144 and CD31 stained both LECs and blood vascular endothelial cells (BECs); in contrast, CD59 and CD105 stained BECs but not LECs. We also showed that antigen-presenting cells (APCs) in the sinuses could be clearly distinguished from LECs by their expression of CD169, and their lack of expression of PROX1 and STAB2, or endothelial markers such as CD144. However, both LECs and sinus APCs were stained with DCN46, an antibody commonly used to detect CD209.
Gov't Doc #: 24733110
URI: https://ahro.austin.org.au/austinjspui/handle/1/12173
DOI: 10.1371/journal.pone.0094781
Journal: PLoS One
URL: https://pubmed.ncbi.nlm.nih.gov/24733110
Type: Journal Article
Subjects: Antigen-Presenting Cells.metabolism
Antigens, CD.metabolism
Cadherins.metabolism
Cell Adhesion Molecules.metabolism
Cell Adhesion Molecules, Neuronal.metabolism
Endothelial Cells.cytology
Gene Expression Regulation
Genetic Markers
Humans
Lectins, C-Type.metabolism
Lymph Nodes.cytology
Lymphatic Vessels.pathology
Microscopy, Fluorescence
Phenotype
Receptors, Cell Surface.metabolism
Sialic Acid Binding Ig-like Lectin 1.metabolism
Vesicular Transport Proteins.metabolism
Appears in Collections:Journal articles

Show full item record

Page view(s)

22
checked on Sep 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.